摘要
Comparative analyses of the pharmacophoric elements required for σ1 and nicotinic ligands led to the identification of a potent and selective σ1 ligand (15). Compound 15 displayed high selectivity for the σ1 receptor (Ki, σ1 = 4.1 nM; Ki, σ2 = 1312 nM) with moderate binding affinity for the DAT (Ki = 373 nM) and NET (Ki = 203 nM) in the PDSP broad screening panel of common CNS neurotransmitter transporters and receptors. The key finding in this present work is that a subtle structural modification could be used as a tool to switch a ligand's selectivity between nAChRs and sigma receptors.
| 源语言 | 英语 |
|---|---|
| 页(从-至) | 1054-1058 |
| 页数 | 5 |
| 期刊 | ACS Medicinal Chemistry Letters |
| 卷 | 3 |
| 期 | 12 |
| DOI | |
| 出版状态 | 已出版 - 13 12月 2012 |
| 已对外发布 | 是 |
指纹
探究 'From α4β2 nicotinic ligands to the discovery of σ1 receptor ligands: Pharmacophore analysis and rational design' 的科研主题。它们共同构成独一无二的指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver